Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3c9fc3cb0028234aedb8df651f9d2e4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
filingDate |
1995-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0154b43cc48683c673f10b59088822f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f2dd54cdf66a6aaf2be564f897036a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd3d7593c237d15c852450689592fb44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b05baec2afdd1f9f47ec573104002fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_801bad320032afa0b566e04d4403d7f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6911e2c7ce328842979d9cb9835425f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de18f7e41e8d2ce42c927046a1eb8f5b |
publicationDate |
2003-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0743856-B1 |
titleOfInvention |
Antigen-based heteropolymers for treating autoimmune diseases |
abstract |
Constructs consisting of antigen-based heteropolymers (AHP's) are provided. The antigen-based heteropolymers comprise at least one monoclonal antibody specific for binding to complement receptor (CR1) site on a human or non-human primate erythrocyte, and the anti-CR1 monoclonal antibody is crosslinked to an antigen specific for a target pathogenic autoantibody. Further provided is a method for treating autoimmune diseases in human or non-human primates using the AHP. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10046056-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265415-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265416-B2 |
priorityDate |
1994-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |